FONAR CORP (FONR) Stock Fundamental Analysis
NASDAQ:FONR - Nasdaq - US3444374058 - Common Stock - Currency: USD
Taking everything into account, FONR scores 5 out of 10 in our fundamental rating. FONR was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While FONR has a great health rating, its profitability is only average at the moment. FONR has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
FONR had positive earnings in the past year.
In the past year FONR had a positive cash flow from operations.
In the past 5 years FONR has always been profitable.
Each year in the past 5 years FONR had a positive operating cash flow.
1.2 Ratios
FONR has a better Return On Assets (3.68%) than 80.21% of its industry peers.
FONR has a Return On Equity of 4.60%. This is in the better half of the industry: FONR outperforms 78.61% of its industry peers.
FONR has a Return On Invested Capital of 4.51%. This is in the better half of the industry: FONR outperforms 77.01% of its industry peers.
The Average Return On Invested Capital over the past 3 years for FONR is in line with the industry average of 7.89%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.68% | ||
| ROE | 4.6% | ||
| ROIC | 4.51% |
ROA(3y)4.96%
ROA(5y)4.84%
ROE(3y)6.44%
ROE(5y)6.47%
ROIC(3y)7.14%
ROIC(5y)7.07%
1.3 Margins
With an excellent Profit Margin value of 7.67%, FONR belongs to the best of the industry, outperforming 80.75% of the companies in the same industry.
In the last couple of years the Profit Margin of FONR has declined.
FONR has a Operating Margin of 11.68%. This is in the better half of the industry: FONR outperforms 78.61% of its industry peers.
In the last couple of years the Operating Margin of FONR has declined.
FONR's Gross Margin of 41.23% is on the low side compared to the rest of the industry. FONR is outperformed by 66.84% of its industry peers.
FONR's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.68% | ||
| PM (TTM) | 7.67% | ||
| GM | 41.23% |
OM growth 3Y-5.46%
OM growth 5Y-8.71%
PM growth 3Y-3.38%
PM growth 5Y-10.22%
GM growth 3Y-3.21%
GM growth 5Y-2.4%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FONR is destroying value.
The number of shares outstanding for FONR has been reduced compared to 1 year ago.
The number of shares outstanding for FONR remains at a similar level compared to 5 years ago.
Compared to 1 year ago, FONR has an improved debt to assets ratio.
2.2 Solvency
FONR has an Altman-Z score of 2.77. This is not the best score and indicates that FONR is in the grey zone with still only limited risk for bankruptcy at the moment.
FONR has a better Altman-Z score (2.77) than 66.31% of its industry peers.
The Debt to FCF ratio of FONR is 0.06, which is an excellent value as it means it would take FONR, only 0.06 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.06, FONR belongs to the best of the industry, outperforming 95.19% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that FONR is not too dependend on debt financing.
The Debt to Equity ratio of FONR (0.00) is better than 70.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Altman-Z | 2.77 |
ROIC/WACC0.5
WACC9.05%
2.3 Liquidity
FONR has a Current Ratio of 10.05. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.
FONR has a better Current ratio (10.05) than 92.51% of its industry peers.
A Quick Ratio of 9.86 indicates that FONR has no problem at all paying its short term obligations.
FONR has a Quick ratio of 9.86. This is amongst the best in the industry. FONR outperforms 92.51% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.05 | ||
| Quick Ratio | 9.86 |
3. Growth
3.1 Past
The earnings per share for FONR have decreased strongly by -21.19% in the last year.
The Earnings Per Share has been decreasing by -7.12% on average over the past years.
Looking at the last year, FONR shows a small growth in Revenue. The Revenue has grown by 0.29% in the last year.
Measured over the past years, FONR shows a small growth in Revenue. The Revenue has been growing by 3.36% on average per year.
EPS 1Y (TTM)-21.19%
EPS 3Y1.78%
EPS 5Y-7.12%
EPS Q2Q%37.05%
Revenue 1Y (TTM)0.29%
Revenue growth 3Y4.6%
Revenue growth 5Y3.36%
Sales Q2Q%5.63%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 13.68, the valuation of FONR can be described as correct.
87.70% of the companies in the same industry are more expensive than FONR, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of FONR to the average of the S&P500 Index (27.51), we can say FONR is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.68 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, FONR is valued cheaper than 98.93% of the companies in the same industry.
FONR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. FONR is cheaper than 93.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.58 | ||
| EV/EBITDA | 2.79 |
4.3 Compensation for Growth
The decent profitability rating of FONR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for FONR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
16
-0.31 (-1.9%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners49.08%
Inst Owner Change0%
Ins Owners2.22%
Ins Owner Change0%
Market Cap101.28M
Analysts0
Price TargetN/A
Short Float %0.81%
Short Ratio1.58
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.68 | ||
| Fwd PE | N/A | ||
| P/S | 0.98 | ||
| P/FCF | 12.58 | ||
| P/OCF | 8.7 | ||
| P/B | 0.59 | ||
| P/tB | 0.62 | ||
| EV/EBITDA | 2.79 |
EPS(TTM)1.17
EY7.31%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.27
FCFY7.95%
OCF(TTM)1.84
OCFY11.5%
SpS16.27
BVpS27.15
TBVpS25.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.68% | ||
| ROE | 4.6% | ||
| ROCE | 5.99% | ||
| ROIC | 4.51% | ||
| ROICexc | 6.18% | ||
| ROICexgc | 6.51% | ||
| OM | 11.68% | ||
| PM (TTM) | 7.67% | ||
| GM | 41.23% | ||
| FCFM | 7.81% |
ROA(3y)4.96%
ROA(5y)4.84%
ROE(3y)6.44%
ROE(5y)6.47%
ROIC(3y)7.14%
ROIC(5y)7.07%
ROICexc(3y)9.85%
ROICexc(5y)9.62%
ROICexgc(3y)10.45%
ROICexgc(5y)10.24%
ROCE(3y)9.49%
ROCE(5y)9.41%
ROICexcg growth 3Y-5.28%
ROICexcg growth 5Y-14.37%
ROICexc growth 3Y-4.76%
ROICexc growth 5Y-13.51%
OM growth 3Y-5.46%
OM growth 5Y-8.71%
PM growth 3Y-3.38%
PM growth 5Y-10.22%
GM growth 3Y-3.21%
GM growth 5Y-2.4%
F-Score6
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 64.01% | ||
| Cap/Sales | 3.49% | ||
| Interest Coverage | 388.27 | ||
| Cash Conversion | 65.96% | ||
| Profit Quality | 101.82% | ||
| Current Ratio | 10.05 | ||
| Quick Ratio | 9.86 | ||
| Altman-Z | 2.77 |
F-Score6
WACC9.05%
ROIC/WACC0.5
Cap/Depr(3y)68.94%
Cap/Depr(5y)98.58%
Cap/Sales(3y)3.32%
Cap/Sales(5y)4.6%
Profit Quality(3y)113.41%
Profit Quality(5y)133.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.19%
EPS 3Y1.78%
EPS 5Y-7.12%
EPS Q2Q%37.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.29%
Revenue growth 3Y4.6%
Revenue growth 5Y3.36%
Sales Q2Q%5.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.92%
EBIT growth 3Y-1.11%
EBIT growth 5Y-5.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-26.36%
FCF growth 3Y-4.82%
FCF growth 5Y-3.64%
OCF growth 1Y-24.06%
OCF growth 3Y-9.62%
OCF growth 5Y-6.24%